ARNA : Summary for Arena Pharmaceuticals, Inc. - Yahoo Finance

U.S. Markets close in 5 hrs 6 mins

Arena Pharmaceuticals, Inc. (ARNA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.47+0.02 (+1.38%)
As of 10:53AM EST. Market open.
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close1.45
Bid1.46 x 10300
Ask1.47 x 5700
Day's Range1.45 - 1.47
52 Week Range1.34 - 2.16
Avg. Volume1,649,345
Market Cap357.8M
PE Ratio (TTM)-3.87
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Arena Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ARNA-US : February 22, 2017
    Capital Cube3 hours ago

    Arena Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ARNA-US : February 22, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Arena Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more (Read more...)

  • PR Newswire8 days ago

    Arena Pharmaceuticals Appoints Three New Members to Board of Directors

    SAN DIEGO, Feb. 14, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) today announced the appointment of three new members to the company's Board of Directors.  Jayson Dallas, M.D., Oliver Fetzer, Ph.D., and Garry A. Neil, M.D. have joined as independent directors.  The new directors are all international business executives with significant drug development and commercial expertise. In addition, current directors Harry F. Hixson, Jr., Ph.D. and Donald D. Belcher will be retiring from the Board at the annual meeting. "I would like to thank Dr. Hixson and Mr. Belcher for their years of service and welcome our new directors to the team," said Tina S. Nova, Ph.D., Chair of the Board.

  • PR Newswire13 days ago

    Arena Pharmaceuticals Announces Three Upcoming Presentations at the 12th Congress of European Crohn's and Colitis Organisation - Inflammatory Bowel Diseases 2017

    SAN DIEGO, Feb. 9, 2017 /PRNewswire/ --  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that Dr. Scott Lee and Professor Tanja Kühbacher will present data on etrasimod (APD334) at the 12th ...